Purchase Order 75N91023P00689

Award Date 8/1/23
Potential Completion Date 7/31/24
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Engene Statistics GMBH, doing business as Engene Statistics Sagl, a for-profit organization based in Switzerland. The $23,530.37 contract is for laboratory testing services to support biomedical research projects involving high throughput data analysis, particularly in the field of cancer...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide testing services in support of biomedical research projects involving high throughput data analysis. With a potential value of $19,123, this purchase order has a completion date of March 14, 2024 and was awarded on November 1, 2023. No major subcontractors or set aside designations were specified. Engene...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order contract valued at $25,000 by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The contract is for laboratory testing services to support the research efforts of the National Cancer Institute. Per the award notice, Engene will provide testing services with no subcontractors involved and no set aside...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, Department of Health and Human Services. The $25,000 purchase order is for testing services to support research efforts through January 31, 2025 with no set aside designation applied. As a privately owned data analytics and statistical consulting company based in Switzerland, Engene Statistics Sagl will...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The $20,000 contract requires Engene to provide laboratory testing services in support of biomedical research projects involving high throughput data analysis. Performance will take place at the National Cancer Institute location in Bethesda, Maryland and...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order for $1 million to $5 million to Engene Statistics Sagl of Switzerland for laboratory testing services. Under this contract, Engene Statistics will provide testing support to advance the National Cancer Institute's biomedical research mission. As a small business located in Switzerland, Engene Statistics will leverage their scientific expertise to help NIH-NCI researchers better understand and treat cancer. The award was made using the NIH Chief Grants Management Officer's contracting vehicle to procure specialized services in support of the agency's goal to reduce the public health burden of cancer through research.

Generated 12/24/23, 6:11 PM